CAP-1 protocol
contains cyclophosphamide, pirarubicin & cisplatin; used in the therapy of recurrent adeno- and adenoidcystic carcinomas in the head & neck
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Therapy Context: Research Results